Evidence-based Consensus On The Use Of Sacubitril Valsartan For Heart Failure Management In India

被引：0

作者：

Sawhney, Jitendra ^{[1
]}

Vasudevan, Karthik ^{[2
]}

Shashikanth, T. ^{[3
]}

Das, Vashisth ^{[4
]}

Raghu, K. ^{[5
]}

Goyal, Naresh ^{[6
]}

Rastogi, Vishal ^{[7
]}

Shrivastava, Sameer ^{[8
]}

Singh, Balbir ^{[9
]}

Mehta, Ashwani ^{[1
]}

Suresh, P. V. ^{[10
]}

Ranjit, G. ^{[11
]}

Kumar, Manoj ^{[9
]}

Jain, Priyank ^{[12
]}

Pandey, Anand ^{[13
]}

机构：

[1] Sir Gangaram Hosp, New Delhi, India

[2] Manipal Hosp, Bangalore, Karnataka, India

[3] Yashoda Hosp, Hyderabad, India

[4] Chinmaya Hrudayalaya, Bangalore, Karnataka, India

[5] Care Hosp, Hyderabad, India

[6] Fortis Hosp, Shalimar Bagh, New Delhi, India

[7] Fortis Escorts, New Delhi, India

[8] Max Hosp, New Delhi, India

[9] Max Hosp, Delhi, India

[10] Narayana Hrudayalaya Inst Med Sci, Bangalore, Karnataka, India

[11] Century Hosp, Hyderabad, India

[12] DNS Hosp, Indore, India

[13] Dharam Shila Narayana Superspecial Hosp, New Delhi, India

来源：

JOURNAL OF CARDIAC FAILURE | 2024年 / 30卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

284

引用

页码：240 / 240

页数：1

共 50 条

[41] The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan
Yandrapalli, Srikanth
Aronow, Wilbert S.
Mondal, Pratik
Chabbott, David R.
ARCHIVES OF MEDICAL SCIENCE, 2017, 13 (05) : 1207 - 1216
[42] The impact of the use of sacubitril/valsartan on clinical and echocardiographic parameters in heart failure patients
Almaghraby, A. Abdallah
Abdelnabi, M.
Oz, T. Kemaloglu
Elgowelly, M.
Saleh, Y.
Badran, H.
EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 240 - 240
[43] SACUBITRIL/VALSARTAN VS ENALAPRIL USE IN HOSPITALIZED PATIENTS WITH HEART FAILURE IN SPAIN
Parrondo Garcia, F. J.
Garcia-Quintana, A.
VALUE IN HEALTH, 2023, 26 (12) : S172 - S172
[44] Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy
Gregorietti, Vanesa
Lopez Fernandez, Teresa
Costa, Diego
Ortega Chahla, Elias
Daniele, Andres J.
CARDIO-ONCOLOGY, 2020, 6 (01)
[45] Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy
Vanesa Gregorietti
Teresa Lopez Fernandez
Diego Costa
Elías Ortega Chahla
Andrés J. Daniele
Cardio-Oncology, 6
[46] ANMCO position paper on the use of sacubitril/valsartan therapy in patients with heart failure
Di Tano, Giuseppe
Di Lenarda, Andrea
Gabrielli, Domenico
Aspromonte, Nadia
De Maria, Renata
Frigerio, Maria
Iacoviello, Massimo
Mortara, Andrea
Murrone, Adriano
Nardi, Federico
Oliva, Fabrizio
Pontremoli, Roberto
Scherillo, Marino
Senni, Michele
Urbinati, Stefano
Gulizia, Michele Massimo
GIORNALE ITALIANO DI CARDIOLOGIA, 2018, 19 (10) : 568 - 590
[47] Reply: Sacubitril/valsartan for Chagas' heart disease heart failure?
Bocchi, Edimar Alcides
Rassi, Salvador
Guimaraes, Guilherme Veiga
ESC HEART FAILURE, 2018, 5 (06): : 1072 - 1073
[48] ASSOCIATION OF HEART FAILURE PATIENTS WITH AND WITHOUT SACUBITRIL-VALSARTAN USE WITH INCIDENT CANCER RISK -REFINE THE ROLE OF SACUBITRIL-VALSARTAN
Hu, W.
ATHEROSCLEROSIS, 2023, 379 : S87 - S87
[49] Update on Heart Failure: Ivabradine and Sacubitril-Valsartan
Kittleson, Michelle M.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (12): : 1483 - 1483
[50] Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure
Vader, Justin M.
Givertz, Michael M.
Starling, Randall C.
McNulty, Steven E.
Anstrom, Kevin J.
Desvigne-Nickens, Patrice
Hernandez, Adrian F.
Braunwald, Eugene
Mann, Douglas L.
JACC-HEART FAILURE, 2022, 10 (07) : 449 - 456

← 1 2 3 4 5 →